0 0 0.0013257791541943 0.0013568521031207 0.00277585010409433 0.00368732327260304 0.00241851119144048 0.00363553502439226
Sign Up Today X
Thanks for submitting the form.
Stockreport

Deaf Toddler Hears For The First Time After Pioneering Gene Therapy [Forbes]

Regeneron Pharmaceuticals, Inc. (REGN)  More Company Research Source: Forbes
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
A toddler has been able to hear for the first time after being treated with a pioneering gene therapy for deafness. The girl who lives in the U.K. according to this article from the , has a hereditary mutation in a gene called otoferlin, an important part of allowing people to sense sound in the cells of the ear. Deafness caused by otoferlin mutations is very rare, accounting for less than 1% of all people who are deaf and only 30-50 people a year in the United States are diagnosed with otoferlin-related deafness. "This is a relatively rare form of deafness," said Dr. Lawrence Lustig, M.D., Chair of Columbia University's Department of Otolaryngology, who was presenting the work at the in Baltimore. "But because we have good cellular preservation in the cochlea, it gives us a wonderful opportunity to intervene in early childhood to try to rescue hearing loss before degeneration occurs," added Lustig who is an investigator on the clinical trial. The is run by biotechnology compan [Read more]
IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
REGN alerts
from News Quantified
REGN
NEWS
REGN
Earnings
REGN
Analyst Actions
REGN
SEC Filings
Stockreport

Deaf Toddler Hears For The First Time After Pioneering Gene Therapy [Forbes]

Regeneron Pharmaceuticals, Inc.  (REGN) 
More Company Research Source: Forbes
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
A toddler has been able to hear for the first time after being treated with a pioneering gene therapy for deafness. The girl who lives in the U.K. according to this article from the , has a hereditary mutation in a gene called otoferlin, an important part of allowing people to sense sound in the cells of the ear. Deafness caused by otoferlin mutations is very rare, accounting for less than 1% of all people who are deaf and only 30-50 people a year in the United States are diagnosed with otoferlin-related deafness. "This is a relatively rare form of deafness," said Dr. Lawrence Lustig, M.D., Chair of Columbia University's Department of Otolaryngology, who was presenting the work at the in Baltimore. "But because we have good cellular preservation in the cochlea, it gives us a wonderful opportunity to intervene in early childhood to try to rescue hearing loss before degeneration occurs," added Lustig who is an investigator on the clinical trial. The is run by biotechnology compan [Read more]
IMPACT SNAPSHOT
EVENT TIME:
REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS